Company Overview
Snapshot
Founded in January 2016 by Dan Faszczyk and Yonatan Levin, KolGene operates with 1–10 employees. The company raised $1.1M across two funding rounds from three investors. In May 2017, KolGene partnered with PreventionGenetics to expand access to genetic testing for clinicians worldwide.
Business overview
KolGene provides a digital platform designed to streamline the ordering of genetic tests from laboratories globally. The company's core technology connects clinicians with a diverse range of genetic tests, enabling them to access necessary diagnostics for patients at competitive prices. KolGene operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Clinical Workflow, serving providers and laboratories within the healthcare industry.
Strategic signal
In January 2018, KolGene launched a new release that automated hospital tracking for genetic test orders. This development indicated the company's focus on enhancing operational efficiency and integrating its platform more deeply into clinical workflows, signaling a move towards greater automation and improved service delivery for healthcare providers in the genetic testing space.
Log in to access full profile ›Company Intelligence Q&A
- What is KolGene's primary business?
- KolGene operates a digital platform that allows clinicians to order genetic tests from various laboratories worldwide, aiming to provide accessible and affordable diagnostic options.
- When was KolGene founded and by whom?
- KolGene was founded in January 2016 by co-founders Dan Faszczyk and Yonatan Levin.
- What significant partnership did KolGene announce in 2017?
- In May 2017, KolGene partnered with PreventionGenetics to offer clinicians worldwide access to PreventionGenetics' comprehensive test menu.
- What was a key product development for KolGene in 2018?
- In January 2018, KolGene released an update that automated the tracking of genetic test orders for hospitals, enhancing clinical workflow efficiency.